A Trial of HRS-9813 in Healthy Subjects

Clinical trial NCT06821464 · COMPLETED

Trial details

NCT number: NCT06821464
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis

Start date: 2025-02-17
Primary completion: 2025-07-27
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.